FindTrial
Sign In

Ultrasound-based evaluation of the effect of passy-muir swallowing and speaking valve on diaphragmatic function in patients with tracheostomy

Ultrasound-based evaluation of the effect of passy-muir swallowing and speaking valve on diaphragmatic function in patients with tracheostomy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056047
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-04-18
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheotomy for neurological disorders

Interventions

PMV group:Nil

Sponsors

Yuandong Hospital, The Third Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. The main primary disease is a central nervous system disease; 2. Tracheostomy is related to the primary disease of the central nervous system; 3. Tracheostomy is not extubated during admission to our department or tracheostomy is performed during hospitalization in our department; 4. The patient can tolerate wearing a talking valve for 30 minutes; 5. The patient signs informed consent.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
diaphragmatic thickness;diaphragmatic excursion;—

Countries

China

Contacts

Public ContactZhiming Tang

Yuandong Hospital, The Third Affiliated Hospital of Sun Yat-sen University, North Park Road, Meixian District, Meizhou city, Guangdong, China

tgzhiming@hotmail.com+86 18502003724

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026